Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases × BHQ880 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1 Multiple Myeloma 1 Bone Diseases 1

Interventions

Zoledronic Acid 3 Denosumab 2 radium Ra 223 dichloride 1 odanacatib 1 etelcalcetide hydrochloride 1 cabozantinib 1 Standard of Care 1 Pamidronate 1 Paclitaxel 1 Exercise 1 Bone Marrow Transplantation 1 BHQ880 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00741377 2013-02-18

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Novartis

Phase 1 Completed

Bone Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡